Adam Koppel Insider Trading $APTX Aptinyx Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam Koppel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam Koppel. Adam Koppel is EVP, Strategy and Bus. Dev. in BIOGEN INC. ($IDPH) and SVP, Chief Strategy Officer in BIOGEN INC. ($IDPH) and Director in PTC THERAPEUTICS, INC. ($PTCT) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in TREVENA INC ($TRVN) and Director in Aptinyx Inc. ($APTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).
Adam Koppel in Aptinyx Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam Koppel: Director
Holdings: 5,558,425 shares
Latest Transaction: Jan 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Adam Koppel in Aptinyx Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APTX, IDPH, CERE, DRNA, PTCT, SLDB, TRVN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2021 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | A | 3.46 | 5,508 | 19,058 | 5,508 | |
| Jan 05 2021 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | A | 3.46 | 5,508 | 19,058 | 5,508 | |
| Apr 02 2020 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | A | 2.16 | 8,296 | 17,919 | 8,296 | |
| Jan 16 2020 | APTX | Aptinyx Inc. | Koppel Adam | Director | Buy | P | 3.00 | 3,333,333 | 9,999,999 | 5,558,425 | 2.2 M to 5.6 M (+149.81 %) |
| May 17 2019 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | A | 3.73 | 40,000 | 149,200 | 40,000 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | C | 0.00 | 50,347,397 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Buy | P | 16.00 | 400,000 | 6,400,000 | 2,225,092 | 1.8 M to 2.2 M (+21.92 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Buy | C | 0.00 | 1,825,092 | 0 | 1,825,092 | 0 to 1.8 M |
| Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | C | 0.00 | 50,347,397 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Buy | P | 16.00 | 400,000 | 6,400,000 | 2,225,092 | 1.8 M to 2.2 M (+21.92 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Buy | C | 0.00 | 1,825,092 | 0 | 1,825,092 | 0 to 1.8 M |
Page: 1